Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H18BrClN2O |
| Molecular Weight | 393.705 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COCC1CN=C(C2=CC(Br)=CC=C2N1C)C3=C(Cl)C=CC=C3
InChI
InChIKey=WABYCCJHARSRBH-UHFFFAOYSA-N
InChI=1S/C18H18BrClN2O/c1-22-13(11-23-2)10-21-18(14-5-3-4-6-16(14)20)15-9-12(19)7-8-17(15)22/h3-9,13H,10-11H2,1-2H3
| Molecular Formula | C18H18BrClN2O |
| Molecular Weight | 393.705 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. | 2004-08 |
|
| General pharmacology of the anxiolytic compound metaclazepam in comparison to other benzodiazepines. | 1985 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:50:04 GMT 2025
by
admin
on
Mon Mar 31 18:50:04 GMT 2025
|
| Record UNII |
C2N2B1303L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1012
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
84031-17-4
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
DTXSID40905121
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
C2N2B1303L
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
SUB08800MIG
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
CHEMBL1290783
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
m7260
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000081172
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
614654
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
C83941
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
1716
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
4495
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
METACLAZEPAM
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY | |||
|
71272
Created by
admin on Mon Mar 31 18:50:04 GMT 2025 , Edited by admin on Mon Mar 31 18:50:04 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |